Alzheimer’s and AMD: could elovanoids be a new therapeutic target?

A research team led by Nicolas Bazan, Louisiana State University (LA, USA) have found a new mechanism by which elovanoids might protect retinal and brain cells against neurodegenerative diseases such as Alzheimer’s and age-related macular degeneration (AMD). The molecules could be used as a new therapeutic approach for Alzheimer’s and AMD. The results have been published online in the Proceedings of the National Academy of Sciences. "It is the first report that elovanoids are potential senolytic therapies because they target and dramatically arrest gene expression engaged in cell disturbances, including senescence gene programs and retina cell death in conditions that...